GLP-1 Medications and Low Blood Sugar (Hypoglycemia)
On their own GLP-1s rarely cause lows, but combined with some diabetes meds the risk rises.
The short answer
By themselves, GLP-1 medications rarely cause low blood sugar (hypoglycemia), because they work in a glucose-dependent way. The risk goes up mainly when they are combined with insulin or sulfonylureas (certain diabetes pills). If you take those, your physician may adjust them to prevent lows.
Why the combination matters
Insulin and sulfonylureas can drive blood sugar down on their own. Add the appetite reduction and metabolic effects of a GLP-1, plus eating less, and lows can happen if doses are not adjusted. This is a key reason to tell your physician every medication you take.
Ready to start?
$199 Skeptics' Trial, see if it works for you
One-time $199 trial with physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for the patient's location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. Standard care starts with a $119 physician review; medication is separate, and compounded semaglutide programs start at $166/month.
Start the 30-day trialSymptoms and what to do
Shakiness, sweating, dizziness, confusion, fast heartbeat, or intense hunger can signal a low. Treat a confirmed low with fast-acting carbohydrate as advised, and tell your physician so doses can be adjusted. If you do not take insulin or a sulfonylurea, significant lows are unlikely, but report any symptoms.
How this relates to what we offer
Our $119 review covers your full medication list, including diabetes medications, so the plan accounts for hypoglycemia risk rather than ignoring it.
What you can start today at New Hope Weight Loss
After a one-time $119 medical review with Dr. Sharma, eligible patients begin physician-supervised compounded semaglutide from $166 a month or compounded tirzepatide from $233 a month, with a $199 one-month Skeptics' Trial. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location. In person in Orange County and by telehealth for eligible patients in California.
Frequently asked questions
Do GLP-1 medications cause low blood sugar?
On their own, rarely, because they act in a glucose-dependent way. The risk rises mainly when combined with insulin or sulfonylureas, which your physician may adjust to prevent lows.
What are symptoms of low blood sugar?
Shakiness, sweating, dizziness, confusion, fast heartbeat, or intense hunger. Treat a confirmed low with fast-acting carbohydrate as advised and tell your physician.
I take insulin. Is it safe to add a GLP-1?
It can be, but doses often need adjusting to prevent lows. This is a physician decision; tell them every medication you take so the plan is safe.
Will I get low blood sugar if I'm not diabetic?
Significant lows are unlikely on a GLP-1 alone if you do not take insulin or a sulfonylurea, but report any symptoms to your clinician.
Does New Hope review my other medications?
Yes. The $119 review covers your full medication list, including diabetes medications, so the plan accounts for hypoglycemia risk.
This article is informational only and not medical advice. Speak with a licensed physician before starting or changing any GLP-1 therapy. Individual results vary. New Hope Weight Loss is a physician-supervised medical weight loss clinic in Costa Mesa, CA. Eligibility for treatment is determined during the medical consultation. Compounded semaglutide and compounded tirzepatide are not the same products as Wegovy®, Ozempic®, Mounjaro®, or Zepbound®.